NCT03781232View on ClinicalTrials.gov

Non-invasive Glucose Measurement With Raman Technology in Patients With Type 1 and Type 2 Diabetes

NACompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

November 22, 2018

Primary Completion Date

August 5, 2019

Study Completion Date

August 5, 2019

Conditions
Diabete MellitusMedical Device
Interventions
DEVICE

Prototype 0.3

Prototype 0.3 is a non-invasive glucose monitoring device using Raman spectroscopy

Trial Locations (2)

83670

m&i-Fachklinik Bad Heilbrunn - Zentrum für Diabetes und Stoffwechselerkrankungen, Bad Heilbrunn

89081

Institut für Diabetes-Technologie, Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm, Ulm

All Listed Sponsors
lead

RSP Systems A/S

INDUSTRY

NCT03781232 - Non-invasive Glucose Measurement With Raman Technology in Patients With Type 1 and Type 2 Diabetes | Biotech Hunter | Biotech Hunter